Surveillance of the Patients with High Risk of Hepatocellular Cancer
- 76 Downloads
Hepatocellular carcinoma (HCC) is the fifth most common cancer among malignancies in men all over the world. It is the third most common leading cause of death. HCC accounts for more than 300,000 deaths in China and more than 650,000 deaths worldwide every year [1, 2, 3].
The only hope for curing HCC is to diagnose it at an early or very early stage. Local ablative treatments such as radiofrequency ablation and/or ethanol injection or resection lead to cure or long-term survival [4, 5]. However, patients diagnosed with advanced-stage HCC are usually treated by chemoembolization or chemotherapy, resulting in a much shorter life expectancy. In order to cure HCC or offer a longer life expectancy, surveillance of those patients with a high risk for HCC is necessary. There are several questions about the surveillance of patients with high risk for HCC. Firstly, is surveillance cost-effective? Secondly, can surveillance provide a diagnosis of HCC in the early stage? Thirdly, does...
The author is very thankful to Dr. Favzia Mai Tung for editing this article.
- 3.Davis GL, Dempster J, Meler JD, et al. Hepatocellular carcinoma: management of an increasingly common problem. Proc (Bayl Univ med Cent). 2008;21(3):266–80.Google Scholar
- 5.Intaraprosong P, Siramolpiwat S, Vilaichone RK, et al. Advances in management of hepatocellular carcinoma. Asian Pac J Cancer Prev. 2016;17(8):3697–703.Google Scholar
- 23.Wong VWS, Chan SL, Mo F, et al. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. J Clin Oncol. 28:1660–5.Google Scholar
- 33.Chan AWH, Chan SL, Mo FKF, et al. Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma. Hindawi Publishing Corporation Disease Markers Volume 2015, Article ID 564057, 10 pages.Google Scholar
- 44.Oka H, Saito A, Ito K, et al. Hepatocellular carcinoma and a-fetoprotein multicenter prospective analysis of newly diagnosed hepatocellular carcinoma with respect to the percentage of Lens culinaris agglutinin-reactive a-fetoprotein1. J Gastroenterol Hepatol. 2001;16:1378–83.CrossRefPubMedGoogle Scholar